Ibandronate Sodium Tablet, Film Coated
Product Images NDC 65862-237

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 65862-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (Blister Carton (Three 150 mg Tablets = Three-month supply))

This is a description of a prescription medication called Ibandronate Sodium Tablets. The dosage usually involves taking one tablet once a month. The package contains three tablets which is supposed to be a three-month supply. This medication contains ibandronate sodium monohydrate which is equivalent to 150mg of fres acid. This package is child-resistant. The text also encourages the pharmacist to provide the medication guide alongside the prescription. The manufacturer of the medication is Aurobindo Pharma USA.*

FDA Label Image

Ibandronate Structure (Ibandronate Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.